These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25453815)

  • 21. Properties of nicked and circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligodeoxynucleotides.
    Yamakawa H; Abe T; Saito T; Takai K; Yamamoto N; Takaku H
    Bioorg Med Chem; 1998 Jul; 6(7):1025-32. PubMed ID: 9730239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-delivery of VP-16 and Bcl-2-targeted antisense on PEG-grafted oMWCNTs for synergistic in vitro anti-cancer effects in non-small and small cell lung cancer.
    Heger Z; Polanska H; Krizkova S; Balvan J; Raudenska M; Dostalova S; Moulick A; Masarik M; Adam V
    Colloids Surf B Biointerfaces; 2017 Feb; 150():131-140. PubMed ID: 27907860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleotide pyrophosphatase/phosphodiesterase 1 is responsible for degradation of antisense phosphorothioate oligonucleotides.
    Wójcik M; Cieślak M; Stec WJ; Goding JW; Koziołkiewicz M
    Oligonucleotides; 2007; 17(1):134-45. PubMed ID: 17461770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel universal linker for efficient synthesis of phosphorothioate oligonucleotides.
    Wang Z; Olsen P; Ravikumar VT
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(3):259-69. PubMed ID: 17454735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PEG-appended beta-(1-->3)-D-glucan schizophyllan to deliver antisense-oligonucleotides with avoiding lysosomal degradation.
    Karinaga R; Koumoto K; Mizu M; Anada T; Shinkai S; Sakurai K
    Biomaterials; 2005 Aug; 26(23):4866-73. PubMed ID: 15763266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid membrane permeability of 2'-modified derivatives of phosphorothioate oligonucleotides.
    Hughes JA; Bennett CF; Cook PD; Guinosso CJ; Mirabelli CK; Juliano RL
    J Pharm Sci; 1994 Apr; 83(4):597-600. PubMed ID: 8046622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets.
    Kawasaki AM; Casper MD; Freier SM; Lesnik EA; Zounes MC; Cummins LL; Gonzalez C; Cook PD
    J Med Chem; 1993 Apr; 36(7):831-41. PubMed ID: 8464037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides.
    Agrawal S
    Biochim Biophys Acta; 1999 Dec; 1489(1):53-68. PubMed ID: 10806997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides.
    Meyer O; Kirpotin D; Hong K; Sternberg B; Park JW; Woodle MC; Papahadjopoulos D
    J Biol Chem; 1998 Jun; 273(25):15621-7. PubMed ID: 9624154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of fibronectin expression by intravitreal administration of antisense oligonucleotides.
    Roy S; Zhang K; Roth T; Vinogradov S; Kao RS; Kabanov A
    Nat Biotechnol; 1999 May; 17(5):476-9. PubMed ID: 10331808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid-modified oligonucleotide conjugates: Insights into gene silencing, interaction with model membranes and cellular uptake mechanisms.
    Ugarte-Uribe B; Grijalvo S; Pertíñez SN; Busto JV; Martín C; Alagia A; Goñi FM; Eritja R; Alkorta I
    Bioorg Med Chem; 2017 Jan; 25(1):175-186. PubMed ID: 27810441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mild and efficient solid-support synthesis of novel oligonucleotide conjugates.
    Habus I; Xie J; Iyer RP; Zhou WQ; Shen LX; Agrawal S
    Bioconjug Chem; 1998; 9(2):283-91. PubMed ID: 9548546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supramolecular assemblies for the cytoplasmic delivery of antisense oligodeoxynucleotide: polyion complex (PIC) micelles based on poly(ethylene glycol)-SS-oligodeoxynucleotide conjugate.
    Oishi M; Hayama T; Akiyama Y; Takae S; Harada A; Yamasaki Y; Nagatsugi F; Sasaki S; Nagasaki Y; Kataoka K
    Biomacromolecules; 2005; 6(5):2449-54. PubMed ID: 16153078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.
    Zhao Q; Matson S; Herrera CJ; Fisher E; Yu H; Krieg AM
    Antisense Res Dev; 1993; 3(1):53-66. PubMed ID: 8495106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemically modified polysaccharide schizophyllan for antisense oligonucleotides delivery to enhance the cellular uptake efficiency.
    Matsumoto T; Numata M; Anada T; Mizu M; Koumoto K; Sakurai K; Nagasaki T; Shinkai S
    Biochim Biophys Acta; 2004 Jan; 1670(2):91-104. PubMed ID: 14738991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new antisense oligonucleotide delivery system based on self-assembled ODN-PEG hybrid conjugate micelles.
    Jeong JH; Kim SW; Park TG
    J Control Release; 2003 Dec; 93(2):183-91. PubMed ID: 14636724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Separation of synthetic phosphorothioate oligonucleotides from phosphodiester-defect species by strong-anion exchange HPLC.
    Bergot BJ; Zon G
    Ann N Y Acad Sci; 1992 Oct; 660():310-2. PubMed ID: 1340142
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular delivery and biological activity of antisense oligonucleotides conjugated to a targeted protein carrier.
    Kang H; Alam MR; Dixit V; Fisher M; Juliano RL
    Bioconjug Chem; 2008 Nov; 19(11):2182-8. PubMed ID: 18826264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol.
    Shoji Y; Ishige H; Tamura N; Iwatani W; Norimatsu M; Shimada J; Mizushima Y
    J Drug Target; 1998; 5(4):261-73. PubMed ID: 9713976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The high binding affinity of phosphorothioate-modified oligomers for Ff gene 5 protein is moderated by the addition of C-5 propyne or 2'-O-methyl modifications.
    Mou TC; Gray DM
    Nucleic Acids Res; 2002 Feb; 30(3):749-58. PubMed ID: 11809888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.